David L. Dai

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein et al. · Blood · 2019 · 363 citations · Full text

Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils

Nathaniel Robichaud, Brian E. Hsu, Roman Istomine et al. · Proceedings of the National Academy of Sciences · 2018 · 107 citations · Full text

Tumor Biology, Lung Metastasis, Cell Regulation +14

Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors

Bin Fan, Ingo K. Mellinghoff, Patrick Y. Wen et al. · Investigational New Drugs · 2019 · 95 citations · Full text

SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation

Xu Zhang, Jung‐Hyun Choi, David L. Dai et al. · Proceedings of the National Academy of Sciences · 2022 · 80 citations · Full text